29 November 2019
Visiongain has launched a new pharma report ‘’North America Extremity Tissue Expanders Market Report 2020-2030’’ by Shape (Anatomical, Crescent, Rectangular, Round, Others), End Users (Burn Centers, Hospitals, Others), and Geography.
North America's extremity tissue expanders market is anticipated to grow at a lucrative CAGR of 3.8% and anticipated to reach USD 99.63 Million by 2030.
The increasing number of trauma-related injuries and cases of serious road accidents are considered to be one of the most significant factors contributing to demand for the drug.
According to the United States Fire Administration, in the year 2015, over 15,000 people suffered burns. Accidents may result in severe upper and lower extremity injuries, as well as bruises and deformities. This often leads to reconstructive surgery with the help of tissue expanders.
Increasing prevalence of congenital deformity and birth defects has also resulted in high market development as congenital abnormalities or birth defects involving lower & upper extremities may involve reconstruction procedures based on tissue expander.
Also, some of the major factors contributing to the growth of North American extremity tissue expanders market are technological advancements, growing tissue expander awareness, improvement in quality patient care, and growing healthcare expenditure. A near-perfect match of color & texture, a high success rate of effective tissue grafting, and limited scarring are some of the advantages of these products.
Due to the presence of developed healthcare facilities, growing healthcare expenditure, and the widespread prevalence of multiple congenital disorders, the United States dominated the North American extremity tissue expanders market in 2018. Also, as per the CDC, in the United States, 1 out of 33 babies born are affected by a birth defect. However, an increase in the number of reconstructive surgeries in the country has resulted in a high demand for these products.
During the forecast period from 2020 to 2030, Canada's extremity tissue expanders market is anticipated to grow at a lucrative CAGR. The growing number of road accidents & trauma injuries have increased demand for these expanders in surgical procedures for leg and arm reconstruction.
North America holds the majority of market share followed by Europe and will continue to dominate in the future as a result of several research projects in the region, coupled with funding for research institutes from the government. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations and launching new products to strengthen their position in the extremity tissue expanders market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the extremity tissue expanders market.
The comprehensive market report features companies such as Allergan plc, KOKEN CO., LTD., Mentor Worldwide LLC, PMT Corporation, Sientra, Inc., Eurosilicone S.A.S., Eurosurgical Ltd., Guangzhou Wanhe Plastic Materials Co. Ltd., Groupe Sebbin, GC Aesthetics PLC, Koken Co. Ltd, Laboratories Arion, Oxtex Ltd., Polytech, Specialty Surgical Products, Inc.., Wright Medical Group among other prominent players. Also, the research study offers market estimation and forecast for the period ranging from 2020-2030 for North America along with regional sub-markets as the U.S. and Canada.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
14 July 2021
Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.